C4 Therapeutics, Inc. Quarterly Return On Assets in % from Q2 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
C4 Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q2 2021 to Q3 2024.
  • C4 Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -27.6 %, a 21.7% increase year-over-year.
  • C4 Therapeutics, Inc. annual Return On Assets for 2023 was -35.8 %, a 32.7% decline from 2022.
  • C4 Therapeutics, Inc. annual Return On Assets for 2022 was -27 %, a 54.2% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -27.6 +7.62 +21.7% Jul 1, 2024 Sep 30, 2024
Q2 2024 -29 +4.65 +13.8% Apr 1, 2024 Jun 30, 2024
Q1 2024 -34 -4.51 -15.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -35.8 -8.82 -32.7% Oct 1, 2023 Dec 31, 2023
Q3 2023 -35.2 -13.6 -62.9% Jul 1, 2023 Sep 30, 2023
Q2 2023 -33.6 -14 -71.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -29.5 -11.1 -60.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 -27 -9.48 -54.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -21.6 -1.7 -8.55% Jul 1, 2022 Sep 30, 2022
Q2 2022 -19.7 +3.12 +13.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 -18.4 Jan 1, 2022 Mar 31, 2022
Q4 2021 -17.5 Oct 1, 2021 Dec 31, 2021
Q3 2021 -19.9 Jul 1, 2021 Sep 30, 2021
Q2 2021 -22.8 Apr 1, 2021 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.